蚊が媒介する感染症の世界市場レポート 2025年

蚊が媒介する感染症市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.0％で45億1,000万米ドルに成長します。予測期間に予想される成長の原動力は、媒介蚊駆除プログラムへの投資の増加、ヘルスケアインフラへの重点化、流行地域への旅行や観光の増加、薬剤耐性蚊の出現、病気撲滅を目指す政府の取り組みなどです。この時期の主な動向としては、殺虫剤処理蚊帳の開発、迅速診断検査キットの導入、媒介蚊対策法の進歩、技術革新、高度な診断ツールの開発などが挙げられます。

海外旅行の増加が蚊媒介性疾患市場の成長を牽引すると予想されます。このような旅行の急増は、パンデミック後のレジャー、ビジネス、同窓会などの需要の増加に加え、アクセスの向上や旅行インフラの改善などが背景にあります。海外旅行は、旅行者を蚊の生息地にさらし、病気を媒介する蚊の移動を容易にし、効果的な媒介蚊対策を複雑にすることで、蚊媒介性疾患の蔓延に一役買っています。例えば、2024年9月、スペインを拠点とする観光機関である国連観光局によると、2024年1月から9月までの国際観光客（宿泊客）の入国者数は約11億人で、2023年の同時期と比べて11％増加しました。その結果、海外旅行の急増が蚊が媒介する感染症市場の成長に寄与しています。

蚊が媒介する感染症市場で事業を展開する企業は、マラリア、デング熱、ジカ熱などの疾患に対する予防効果を高めるため、進化型蚊よけ剤などの革新的な製品の開発に注力しています。進化した蚊よけ剤には、長時間効果が持続する成分や、マイクロカプセル化、天然化合物、ウェアラブルデバイスなどの技術を取り入れ、防御力を高めた製品が含まれます。例えば、2023年3月、オーストラリアを拠点とする家庭用殺虫剤ブランドMorteinは、蚊から身を守るために設計された高度な液体蒸発器Mortein Smart+を発売しました。この製品は、電源を切った後でも2時間の残効性を持ち、蚊が媒介する感染症の脅威の増大に、より迅速かつ効果的な忌避効果で対処します。今回の発売は、特に蚊が媒介する病気との闘いにおいて、家族のために信頼できるソリューションを提供するというモルテインのコミットメントを示すものです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の蚊が媒介する感染症PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の蚊が媒介する感染症市場：成長率分析
• 世界の蚊が媒介する感染症市場の実績：規模と成長、2019年～2024年
• 世界の蚊が媒介する感染症市場の予測：規模と成長、2024年～2029年、2034年
• 世界の蚊が媒介する感染症総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の蚊が媒介する感染症市場：疾患タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• マラリア
• デング熱
• 黄熱病
• ウエストナイルウイルス
• チクングニア熱
• ジカウイルス
• その他の疾患タイプ
• 世界の蚊が媒介する感染症市場：治療タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 薬
• 予防接種
• ベクトル制御法
• 免疫療法
• 支持療法
• その他の治療タイプ
• 世界の蚊が媒介する感染症市場：エンドユーザー別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 病院
• クリニック
• 診断センター
• 研究機関
• 政府機関
• 非政府組織
• その他のエンドユーザー
• 世界の蚊が媒介する感染症市場、マラリアの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 熱帯熱マラリア原虫
• 三日熱マラリア原虫
• その他のマラリアの種類
• 世界の蚊が媒介する感染症市場、デング熱の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• デング熱
• 重症デング熱（デング出血熱）
• 世界の蚊が媒介する感染症市場、黄熱病の種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 急性黄熱病
• 慢性黄熱病
• 世界の蚊が媒介する感染症市場、ウエストナイルウイルスの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 神経侵襲性疾患（脳炎、髄膜炎）
• 非神経侵襲性疾患
• 世界の蚊が媒介する感染症市場、チクングニア熱のサブセグメンテーション（タイプ別）、実績と予測、2019年～2024年、2024年～2029年、2034年
• 急性チクングニア熱
• 慢性チクングニア熱
• 世界の蚊が媒介する感染症市場、ジカウイルスの種類別サブセグメンテーション、実績と予測、2019年～2024年、2024年～2029年、2034年
• 急性ジカウイルス感染症
• 先天性ジカ症候群
• 世界の蚊が媒介する感染症市場、その他の疾患タイプのサブセグメンテーション、タイプ別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 日本脳炎
• ラクロス脳炎
• 東部ウマ脳炎（EEE）
• その他の蚊媒介感染症

第7章 地域別・国別分析

• 世界の蚊が媒介する感染症市場：地域別、実績と予測、2019年～2024年、2024年～2029年、2034年
• 世界の蚊が媒介する感染症市場：国別、実績と予測、2019年～2024年、2024年～2029年、2034年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 蚊が媒介する感染症市場：競合情勢
• 蚊が媒介する感染症市場：企業プロファイル
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Novartis AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• GlaxoSmithKline plc
• Syngenta
• Takeda Pharmaceuticals
• Eisai Co. Ltd.
• Sun Pharmaceutical Industries Ltd.
• Serum Institute of India Pvt. Ltd.
• Orkin Inc.
• RTI International
• Emergent BioSolutions
• Valneva SE
• BioCryst Pharmaceuticals Inc.
• Bharat Biotech
• Vector Control International
• Clarke Environmental Mosquito Management
• Inovio Pharmaceuticals

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 蚊が媒介する感染症市場2029年：新たな機会を提供する国
• 蚊が媒介する感染症市場2029年：新たな機会を提供するセグメント
• 蚊が媒介する感染症市場2029年：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Mosquito-borne diseases are a category of infectious illnesses caused by parasites, viruses, and bacteria transmitted to humans through the bites of infected female mosquitoes. These diseases pose significant health risks, contributing to increased morbidity and mortality rates, and highlighting the need for effective prevention and control strategies in both endemic and non-endemic regions worldwide.

The primary types of mosquito-borne diseases include malaria, dengue, yellow fever, West Nile virus, chikungunya, Zika virus, and others. Malaria is a mosquito-borne illness caused by Plasmodium parasites, transmitted to humans through the bites of infected female Anopheles mosquitoes. It involves various treatment options, such as medication, vaccination, vector control methods, immunotherapy, supportive care, and more, serving a wide range of end users, including hospitals, clinics, diagnostic centers, research institutes, government organizations, and non-governmental organizations.

The mosquito-borne diseases market research report is one of a series of new reports from The Business Research Company that provides mosquito-borne diseases market statistics, including mosquito-borne diseases industry global market size, regional shares, competitors with a mosquito-borne diseases market share, detailed mosquito-borne diseases market segments, market trends and opportunities, and any further data you may need to thrive in the mosquito-borne diseases industry. This mosquito-borne disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The mosquito borne diseases market size has grown strongly in recent years. It will grow from $3.06 billion in 2024 to $3.31 billion in 2025 at a compound annual growth rate (CAGR) of 8.3%. The growth during the historic period can be attributed to the increasing prevalence of malaria and dengue, rising global temperatures, insufficient public health infrastructure, urbanization and population growth, and heightened healthcare awareness.

The mosquito borne diseases market size is expected to see strong growth in the next few years. It will grow to $4.51 billion in 2029 at a compound annual growth rate (CAGR) of 8.0%. The growth expected in the forecast period is driven by rising investments in vector control programs, a stronger focus on healthcare infrastructure, an increase in travel and tourism to endemic regions, the emergence of drug-resistant mosquito strains, and government efforts aimed at disease eradication. Key trends in this period include the development of insecticide-treated bed nets, the introduction of rapid diagnostic test kits, advancements in vector control methods, technological innovations, and the creation of advanced diagnostic tools.

The rise in international travel is expected to drive the growth of the mosquito-borne diseases market. This surge in travel is fueled by the increased demand for leisure, business, and reunions post-pandemic, alongside enhanced accessibility and improved travel infrastructure. International travel plays a role in the spread of mosquito-borne diseases by exposing travelers to mosquito habitats, facilitating the movement of disease-carrying mosquitoes, and complicating effective vector control measures. For example, in September 2024, the UN Tourism, a Spain-based tourism agency, reported approximately 1.1 billion international tourist arrivals (overnight visitors) from January to September 2024, marking an 11% increase compared to the same period in 2023. As a result, the surge in international travel is contributing to the growth of the mosquito-borne diseases market.

Companies operating in the mosquito-borne diseases market are focusing on developing innovative products, such as advanced mosquito repellents, to improve protection against diseases such as malaria, dengue, and Zika. Advanced mosquito repellents include products that incorporate long-lasting, effective ingredients or technologies, such as microencapsulation, natural compounds, or wearable devices, to offer enhanced protection. For instance, in March 2023, Mortein, an Australia-based household insecticide brand, launched the Mortein Smart+, an advanced liquid vaporizer designed to provide protection against mosquitoes. This product offers two hours of residual protection even after being turned off, addressing the growing threat of mosquito-borne diseases with faster and more effective repellency. The launch demonstrates Mortein's commitment to providing reliable solutions for families, particularly in the fight against mosquito-borne illnesses.

In February 2024, Kao Corporation, a Japan-based chemicals company, formed a partnership with Earth Corporation to address mosquito-borne diseases in Thailand. Together, they introduced the ARS Mos Shooter, an eco-friendly spray formulated with advanced surfactant technology and lemongrass essential oil to impede mosquito flight. This initiative aims to reduce the incidence of dengue fever by encouraging community involvement and raising public health awareness. Earth Corporation is a Japan-based company that produces household products and insecticides and is actively involved in addressing mosquito-borne infectious diseases.

Major players in the mosquito borne diseases market are Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Syngenta, Takeda Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India Pvt. Ltd., Orkin Inc., RTI International, Emergent BioSolutions, Valneva SE, BioCryst Pharmaceuticals Inc., Bharat Biotech, Vector Control International, Clarke Environmental Mosquito Management, Inovio Pharmaceuticals, and Oxitec Ltd.

North America was the largest region in the mosquito borne diseases market in 2024. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in mosquito borne diseases report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the mosquito borne diseases market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The mosquito borne diseases market consists of sales of insecticide-treated bed nets, antimalarial medications, adult mosquito control products, diagnostic kits, and protective clothing. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Mosquito Borne Diseases Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on mosquito borne diseases market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for mosquito borne diseases ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The mosquito borne diseases market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Disease Type: Malaria; Dengue; Yellow Fever; West Nile Virus; Chikungunya; Zika Virus; Other Disease Types
• 2) By Treatment Type: Medication; Vaccination; Vector Control Methods; Immunotherapy; Supportive Care; Other Treatment Types
• 3) By End User: Hospitals; Clinics; Diagnostic Centers; Research Institutes; Government Organizations; Non-Governmental Organizations; Other End Users
• Subsegments:
• 1) By Malaria: Plasmodium Falciparum Malaria; Plasmodium Vivax Malaria; Other Malaria Types
• 2) By Dengue: Dengue Fever; Severe Dengue (Dengue Hemorrhagic Fever)
• 3) By Yellow Fever: Acute Yellow Fever; Chronic Yellow Fever
• 4) By West Nile Virus: Neuroinvasive Disease (Encephalitis, Meningitis); Non-neuroinvasive Disease
• 5) By Chikungunya: Acute Chikungunya; Chronic Chikungunya
• 6) By Zika Virus: Acute Zika Infection; Congenital Zika Syndrome
• 7) By Other Disease Types: Japanese Encephalitis; La Crosse Encephalitis; Eastern Equine Encephalitis (EEE); Other Mosquito-Borne Infections
• Companies Mentioned:Johnson & Johnson; Merck & Co. Inc.; Sanofi S.A.; Abbott Laboratories; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Mosquito Borne Diseases Market Characteristics

3. Mosquito Borne Diseases Market Trends And Strategies

4. Mosquito Borne Diseases Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Mosquito Borne Diseases Growth Analysis And Strategic Analysis Framework

• 5.1. Global Mosquito Borne Diseases PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Mosquito Borne Diseases Market Growth Rate Analysis
• 5.4. Global Mosquito Borne Diseases Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Mosquito Borne Diseases Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Mosquito Borne Diseases Total Addressable Market (TAM)

6. Mosquito Borne Diseases Market Segmentation

• 6.1. Global Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Malaria
• Dengue
• Yellow Fever
• West Nile Virus
• Chikungunya
• Zika Virus
• Other Disease Types
• 6.2. Global Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Medication
• Vaccination
• Vector Control Methods
• Immunotherapy
• Supportive Care
• Other Treatment Types
• 6.3. Global Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Diagnostic Centers
• Research Institutes
• Government Organizations
• Non-Governmental Organizations
• Other End Users
• 6.4. Global Mosquito Borne Diseases Market, Sub-Segmentation Of Malaria, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Plasmodium Falciparum Malaria
• Plasmodium Vivax Malaria
• Other Malaria Types
• 6.5. Global Mosquito Borne Diseases Market, Sub-Segmentation Of Dengue, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Dengue Fever
• Severe Dengue (Dengue Hemorrhagic Fever)
• 6.6. Global Mosquito Borne Diseases Market, Sub-Segmentation Of Yellow Fever, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Yellow Fever
• Chronic Yellow Fever
• 6.7. Global Mosquito Borne Diseases Market, Sub-Segmentation Of West Nile Virus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Neuroinvasive Disease (Encephalitis, Meningitis)
• Non-neuroinvasive Disease
• 6.8. Global Mosquito Borne Diseases Market, Sub-Segmentation Of Chikungunya, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Chikungunya
• Chronic Chikungunya
• 6.9. Global Mosquito Borne Diseases Market, Sub-Segmentation Of Zika Virus, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Acute Zika Infection
• Congenital Zika Syndrome
• 6.10. Global Mosquito Borne Diseases Market, Sub-Segmentation Of Other Disease Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Japanese Encephalitis
• La Crosse Encephalitis
• Eastern Equine Encephalitis (EEE)
• Other Mosquito-Borne Infections

7. Mosquito Borne Diseases Market Regional And Country Analysis

• 7.1. Global Mosquito Borne Diseases Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Mosquito Borne Diseases Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Mosquito Borne Diseases Market

• 8.1. Asia-Pacific Mosquito Borne Diseases Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Mosquito Borne Diseases Market

• 9.1. China Mosquito Borne Diseases Market Overview
• 9.2. China Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Mosquito Borne Diseases Market

• 10.1. India Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Mosquito Borne Diseases Market

• 11.1. Japan Mosquito Borne Diseases Market Overview
• 11.2. Japan Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Mosquito Borne Diseases Market

• 12.1. Australia Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Mosquito Borne Diseases Market

• 13.1. Indonesia Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Mosquito Borne Diseases Market

• 14.1. South Korea Mosquito Borne Diseases Market Overview
• 14.2. South Korea Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Mosquito Borne Diseases Market

• 15.1. Western Europe Mosquito Borne Diseases Market Overview
• 15.2. Western Europe Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Mosquito Borne Diseases Market

• 16.1. UK Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Mosquito Borne Diseases Market

• 17.1. Germany Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Mosquito Borne Diseases Market

• 18.1. France Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Mosquito Borne Diseases Market

• 19.1. Italy Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Mosquito Borne Diseases Market

• 20.1. Spain Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Mosquito Borne Diseases Market

• 21.1. Eastern Europe Mosquito Borne Diseases Market Overview
• 21.2. Eastern Europe Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Mosquito Borne Diseases Market

• 22.1. Russia Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Mosquito Borne Diseases Market

• 23.1. North America Mosquito Borne Diseases Market Overview
• 23.2. North America Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Mosquito Borne Diseases Market

• 24.1. USA Mosquito Borne Diseases Market Overview
• 24.2. USA Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Mosquito Borne Diseases Market

• 25.1. Canada Mosquito Borne Diseases Market Overview
• 25.2. Canada Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Mosquito Borne Diseases Market

• 26.1. South America Mosquito Borne Diseases Market Overview
• 26.2. South America Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Mosquito Borne Diseases Market

• 27.1. Brazil Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Mosquito Borne Diseases Market

• 28.1. Middle East Mosquito Borne Diseases Market Overview
• 28.2. Middle East Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Mosquito Borne Diseases Market

• 29.1. Africa Mosquito Borne Diseases Market Overview
• 29.2. Africa Mosquito Borne Diseases Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Mosquito Borne Diseases Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Mosquito Borne Diseases Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Mosquito Borne Diseases Market Competitive Landscape And Company Profiles

• 30.1. Mosquito Borne Diseases Market Competitive Landscape
• 30.2. Mosquito Borne Diseases Market Company Profiles
  • 30.2.1. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis AG Overview, Products and Services, Strategy and Financial Analysis

31. Mosquito Borne Diseases Market Other Major And Innovative Companies

• 31.1. GlaxoSmithKline plc
• 31.2. Syngenta
• 31.3. Takeda Pharmaceuticals
• 31.4. Eisai Co. Ltd.
• 31.5. Sun Pharmaceutical Industries Ltd.
• 31.6. Serum Institute of India Pvt. Ltd.
• 31.7. Orkin Inc.
• 31.8. RTI International
• 31.9. Emergent BioSolutions
• 31.10. Valneva SE
• 31.11. BioCryst Pharmaceuticals Inc.
• 31.12. Bharat Biotech
• 31.13. Vector Control International
• 31.14. Clarke Environmental Mosquito Management
• 31.15. Inovio Pharmaceuticals

32. Global Mosquito Borne Diseases Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Mosquito Borne Diseases Market

34. Recent Developments In The Mosquito Borne Diseases Market

35. Mosquito Borne Diseases Market High Potential Countries, Segments and Strategies

• 35.1 Mosquito Borne Diseases Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Mosquito Borne Diseases Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Mosquito Borne Diseases Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer